GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lin BioScience Inc (ROCO:6696) » Definitions » Common Stock

Lin BioScience (ROCO:6696) Common Stock : NT$724.76 Mil (As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Lin BioScience Common Stock?

Lin BioScience's quarterly common stock increased from Jun. 2022 (NT$721.84 Mil) to Dec. 2022 (NT$724.01 Mil) and increased from Dec. 2022 (NT$724.01 Mil) to Jun. 2023 (NT$724.76 Mil).

Lin BioScience's annual common stock increased from Dec. 2021 (NT$691.32 Mil) to Dec. 2022 (NT$724.01 Mil) and increased from Dec. 2022 (NT$724.01 Mil) to Dec. 2023 (NT$785.56 Mil).


Lin BioScience Common Stock Historical Data

The historical data trend for Lin BioScience's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lin BioScience Common Stock Chart

Lin BioScience Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial 595.00 687.15 691.32 724.01 785.56

Lin BioScience Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 691.32 721.84 724.01 724.76 785.56

Lin BioScience Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Lin BioScience (ROCO:6696) Business Description

Traded in Other Exchanges
N/A
Address
Zhongxiao East Road, 12th Floor, No. 68, Section 5, Xinyi District, Taipei City, TWN, 110
Lin BioScience Inc is a drug development company. It specializes in therapies for diseases with unmet medical needs. Its novel pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in oncology, ophthalmology, cardiovascular, and metabolic disease.

Lin BioScience (ROCO:6696) Headlines

No Headlines